000 | 01278 a2200349 4500 | ||
---|---|---|---|
005 | 20250513225926.0 | ||
264 | 0 | _c20010315 | |
008 | 200103s 0 0 eng d | ||
022 | _a1073-9688 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMatsuki, T | |
245 | 0 | 0 |
_aTNF-alpha modulates arteriolar reactivity secondary to a change in intimal permeability. _h[electronic resource] |
260 |
_bMicrocirculation (New York, N.Y. : 1994) _cDec 2000 |
||
300 |
_a411-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArachidonic Acid _xmetabolism |
650 | 0 | 4 |
_aArginine Vasopressin _xpharmacology |
650 | 0 | 4 |
_aArterioles _xdrug effects |
650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 |
_aIndomethacin _xpharmacology |
650 | 0 | 4 |
_aInflammation Mediators _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMesocricetus |
650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
700 | 1 | _aDuling, B R | |
773 | 0 |
_tMicrocirculation (New York, N.Y. : 1994) _gvol. 7 _gno. 6 Pt 1 _gp. 411-8 |
|
999 |
_c11082366 _d11082366 |